Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated homocysteine is associated with increased rates of epigenetic aging in a population with mild cognitive impairment

Elevated plasma total homocysteine (tHcy) is associated with the development of Alzheimer's disease and other forms of dementia. In this study, we report the relationship between tHcy and epigenetic age in older adults with mild cognitive impairment from the VITACOG study. Epigenetic age and ra...

Detaylı Bibliyografya
Asıl Yazarlar:	Holmes, HE, Valentin, RE, Jernerén, F, de Jager Loots, CA, Refsum, H, Smith, AD, Guarente, L, Dellinger, RW, Sampson, D, Alzheimer's Disease Neuroimaging Initiative
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Wiley Open Access 2024

Benzer Materyaller

CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia.
Yazar:: Pan Fu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Early diagnosis of Alzheimer’s disease and mild cognitive impairment using MRI analysis and machine learning algorithms
Yazar:: Helia Givian, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
Yazar:: Jorge Garcia Condado, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment
Yazar:: Matteo De Marco, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Uncovering heterogeneous cognitive trajectories in mild cognitive impairment: a data-driven approach
Yazar:: Xiwu Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial.
Yazar:: de Jager, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: A randomized controlled trial
Yazar:: De Jager, C, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Associations between Neuropsychiatric Symptoms and Alzheimer’s Disease Biomarkers in People with Mild Cognitive Impairment
Yazar:: Giulia Arenare, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Choroid plexus volumes and auditory verbal learning scores are associated with conversion from mild cognitive impairment to Alzheimer's disease
Yazar:: Michael J. Pearson, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.
Yazar:: Christian Gaser, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Yazar:: Ali Azargoonjahromi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Sleep and nighttime behavior disorders in older adults: associations with hypercholesterolemia and hypertriglyceridemia at baseline, and a predictive analysis of incident cases at 12 months follow-up
Yazar:: Asma Hallab, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer’s disease
Yazar:: Yi Chen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Alteration in temporal-cerebellar effective connectivity can effectively distinguish stable and progressive mild cognitive impairment
Yazar:: Chen Xue, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Episodic memory network characteristics in patients with amnestic mild cognitive impairment accompanied by executive function impairment
Yazar:: Chao Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer’s Disease or Mild Cognitive Impairment
Yazar:: Lanlan Li, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Elevated homocysteine and N-methyl-d-aspartate-receptor antibodies as a cause of behavioural and cognitive decline in 22q11.2 deletion syndrome.
Yazar:: Jones, S, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Predicting the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease Using an Explainable AI Approach
Yazar:: Gerasimos Grammenos, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Association of CSF GAP-43 and <i>APOE</i> ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
Yazar:: Yueli Zhu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Directed network motifs in Alzheimer's disease and mild cognitive impairment.
Yazar:: Eric J Friedman, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Detection of Alzheimer’s Disease Using Hybrid Meta-ROI of MRI Structural Images
Yazar:: Xiaoming Zheng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

The effect of plasma cortisol on hippocampal atrophy and clinical progression in mild cognitive impairment
Yazar:: Silke White, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment
Yazar:: Yixue Feng, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment
Yazar:: Annie M. Racine, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods
Yazar:: Baiwen Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
Yazar:: Feng Xing, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Homocysteine, B vitamins, and cognitive impairment
Yazar:: Smith, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Homocysteine, B vitamins, and cardiovascular disease
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Homocysteine, B vitamins, and cardiovascular disease.
Yazar:: Refsum, H, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Sex-dependent association of serum uric acid levels with amyloid accumulation among amyloid-positive older adults.
Yazar:: Guanan Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Explainability of three-dimensional convolutional neural networks for functional magnetic resonance imaging of Alzheimer's disease classification based on gradient-weighted class activation mapping.
Yazar:: Boyue Song, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Imputation-Based Variable Selection Method for Block-Wise Missing Data When Integrating Multiple Longitudinal Studies
Yazar:: Zhongzhe Ouyang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Identification of Disease-Related Genes That Are Common between Alzheimer’s and Cardiovascular Disease Using Blood Genome-Wide Transcriptome Analysis
Yazar:: Taesic Lee, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

A Novel Coupling Model of Physiological Degradation and Emotional State for Prediction of Alzheimer’s Disease Progression
Yazar:: Jiawei Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Fast score test with global null estimation regardless of missing genotypes.
Yazar:: Shuntaro Sato, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment
Yazar:: Mingxi Dang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment
Yazar:: Cosimo Tuena, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Two for tau: automated model discovery reveals two-stage tau aggregation dynamics in Alzheimer’s disease
Yazar:: Stockman, CA, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Distinct spatiotemporal subtypes of amyloid deposition are associated with diverging disease profiles in cognitively normal and mild cognitive impairment individuals
Yazar:: Yuqing Sun, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)